This website uses cookies to enhance the user experience.
21st logo
||
H

HØSE AS989 088 548

Limited company
Bauneveien 7A 4328 SANDNES, Norge

HØSE AS

Operating
Investering i verdipapirer samt hva hermed står i forbindelse.
Investering i aksjer samt hva hermed står i forbindelse.

Organization

Chairman of the board
Years since formation
20 years
since Jan 25, 2006
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
118
1 share class
Total number of shareholders
3
persons

Financials

Annual total result 2025
2,966,226
NOK
Total equity 2025
93,102,504
NOK
Last update: Jul 1, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-
Alternate Member-

Others

NameRoleShares
A
AAUDIT AS
Auditor-
R
RELEVANT REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
67.8 %
directly
-
23.73 %
directly
-
8.47 %
directly
Last update: Oct 23, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
80
67.8 %
Ordinary shares
28
23.73 %
Ordinary shares
10
8.47 %

Shares owned by the HØSE AS

NameShare classTotal number of sharesShare
G
GAND EIENDOM AS
Ordinary shares
10,500
50 %
A
AQUA ALARM AS
A-shares
64,482
6.34 %
C
CIRCIO HOLDING ASA
Ordinary shares
6,340,219
4.41 %
A
ADJUTEC PHARMA AS
Ordinary shares
1,511
3.08 %
A
AUGE GROUP AS
Ordinary shares
273,731
1.96 %
E
EVERT AS
Ordinary shares
157,272
1.17 %
S
SKYFRI GROUP AS
Ordinary shares
500,000
0.87 %
S
SALT VALUE AS
Ordinary shares
1,382,000
0.85 %
C
CODELAB CAPITAL AS
Ordinary shares
80,300
0.56 %
P
PCI BIOTECH HOLDING ASA
Under liquidation
Ordinary shares
200,000
0.54 %
A
ARENDALS FOSSEKOMPANI ASA
Ordinary shares
79,680
0.14 %
G
GREENCAP SOLUTIONS AS
Ordinary shares
30,000
0.14 %
N
NEXT BIOMETRICS GROUP ASA
Under liquidation
Ordinary shares
153,010
0.13 %
L
LYTIX BIOPHARMA ASA
Ordinary shares
74,530
0.11 %
T
TECHSTEP ASA
Ordinary shares
32,500
0.09 %
L
LIFECARE ASA
Ordinary shares
16,185
0.08 %
O
ONCOINVENT ASA
Ordinary shares
310,065
0.07 %
I
IDEX BIOMETRICS ASA
Ordinary shares
31,207
0.05 %
H
HOFSETH BIOCARE ASA
Ordinary shares
145,000
0.04 %
S
SOFTOX SOLUTIONS AS
Ordinary shares
1,010,000
0.04 %
V
VESTERÅLEN HAVBRUK AS
Ordinary shares
10,963
0.03 %
S
SOFTOX WOUND & SKIN CARE AS
Ordinary shares
1,010,000
0.02 %
H
HYDROGENPRO ASA
Ordinary shares
199
< 0.01 %
O
OKEA ASA
Ordinary shares
3,000
< 0.01 %
O
OTOVO ASA
Ordinary shares
23,623
< 0.01 %
P
PROXIMAR SEAFOOD AS
Ordinary shares
50,000
< 0.01 %
T
TEKNA HOLDING ASA
Ordinary shares
400
< 0.01 %
G
GREEN MINERALS AS
Ordinary shares
1,000
< 0.01 %
N
NORDIC SEMICONDUCTOR ASA
Ordinary shares
250
< 0.01 %
C
CAMBI ASA
Ordinary shares
10,000
< 0.01 %
N
NYKODE THERAPEUTICS ASA
Ordinary shares
4,100
< 0.01 %
Last update: Sep 25, 2026

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
0
0
0
0
0
Annual Total Result
2,966,226
-8,230,033
881,666
47,928,562
-1,614,276
Total assets
93,261,480
95,258,033
106,547,727
121,489,114
88,611,254
Total liabilities
158,976
21,214
2,675
12,837,588
102,753
Total equity
93,102,504
95,236,819
106,545,052
108,651,526
88,508,501

P&L

Year20252024202320222021
Total operating income
0
0
0
0
0
Total operating costs
417,107
461,802
431,459
357,572
301,852
Operating result
-417,107
-461,802
-431,459
-357,572
-301,852
Financial income/costs
4,411,981
-7,527,515
510,178
48,372,941
-1,216,901
Profit before tax
3,994,875
-7,989,317
78,719
48,015,370
-1,518,753
Total tax & extraordinary income/cost
1,028,649
240,716
-802,947
86,808
95,523
Annual Total Result
2,966,226
-8,230,033
881,666
47,928,562
-1,614,276

Balance overview

Year20252024202320222021
Total fixed assets
50,614,596
56,183,788
42,659,497
42,861,850
58,717,609
Total current assets
42,646,884
39,074,245
63,888,230
78,627,264
29,893,645
Total assets
93,261,480
95,258,033
106,547,727
121,489,114
88,611,254
Short term debt
158,976
21,214
2,675
12,837,588
102,753
Long term debt
0
0
0
0
0
Total liabilities
158,976
21,214
2,675
12,837,588
102,753
Contributed capital
421,840
421,840
421,840
410,040
410,040
Retained earnings
92,680,665
94,814,979
106,123,212
108,241,486
88,098,461
Total equity
93,102,504
95,236,819
106,545,052
108,651,526
88,508,501
Total equity and liabilities
93,261,480
95,258,033
106,547,727
121,489,114
88,611,254

Classification

21st company classification
BETA
Individual SMB enterprise
Type of organization
Limited company
Standard industrial classification